#regulatory-risks

#regulatory-risks

Hims & Hers Health is experiencing significant growth but faces challenges from a partnership fallout and regulatory risks.

Oscar Health's stock surged in June 2025 due to strong earnings, but a subsequent crash raised doubts about its recovery amidst regulatory and market challenges.

CrowdStrike is cutting 5% of its workforce to enhance efficiency amid evolving market trends and AI integration.

Home equity investment products offer benefits but carry significant risks, including regulatory scrutiny and credit risk due to weak consumer profiles.